Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
about
Prescription Sedative Misuse and AbuseIn the Zzz zone: the effects of Z-drugs on human performance and drivingThe Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.Parasomnias: an updated review.Good night and good luck: norepinephrine in sleep pharmacologyRisk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults.Hypnotics' association with mortality or cancer: a matched cohort study.The clinical and forensic toxicology of Z-drugs.Persistent psychosis after abuse of high dose of zolpidem.Prevalence and factors associated with off-label antidepressant prescriptions for insomniaZolpidem ingestion, automatisms, and sleep driving: a clinical and legal case seriesIs Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan.Restless nocturnal eating: a common feature of Willis-Ekbom Syndrome (RLS)Treatment of Insomnia, Insomnia Symptoms, and Obstructive Sleep Apnea During and After Menopause: Therapeutic ApproachesTwo cases of zolpidem-associated homicide.Association between GABA(A) receptor subunit gene cluster and zolpidem-induced complex sleep behaviors in Han Chinese.A comparison of complex sleep behaviors with two short-acting Z-hypnosedative drugs in nonpsychotic patientsManaging insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon.National use of prescription medications for insomnia: NHANES 1999-2010.The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in ratsFast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness.Violence in sleep.A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.Zolpidem for insomnia.Sleep-related eating disorder and its associated conditions.Prevalence and clinical correlates of flunitrazepam-related complex sleep behaviors.Psychiatric Illness and Parasomnias: a Systematic Review.Reversal of a Suspected Paradoxical Reaction to Zopiclone with Flumazenil.Eszopiclone-induced Parasomnia with Suicide Attempt: A Case Report.Sodium oxybate-induced sleep driving and sleep-related eating disorder.Zolpidem Induced Sleep-related Eating and Complex Behaviors in a Patient with Obstructive Sleep Apnea and Restless Legs Syndrome.Darwin's Predisposition and the Restlessness that Drives Sleepwalking.Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008.Sleepwalking.Sleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour.Restless Eating, Restless Legs, and Sleep Related Eating Disorder.Sleep and violence.Sleepwalking in Parkinson's disease: a questionnaire-based survey.Recorded atypical hallucinations in psychotic and affective disorders and associations with non-benzodiazepine hypnotic use: the South London and Maudsley Case Register
P2860
Q26785474-65FA559C-B438-4F84-AA86-4E8A16126ADDQ26861336-9708556F-6117-4293-87E8-0B3E838F87CBQ30362407-3F9BFE61-7A40-43F7-86BD-433BCF81B740Q30526455-2704C43C-22E7-4452-9D9E-E5D9928A45A9Q33615826-3BB0F238-9ED2-4904-936E-B62F8810A14FQ34233363-5830A235-21A4-431B-9A79-42E7232C233AQ34257362-83ACA143-991B-4BC0-9878-43D50B02EB17Q34327511-E8F53372-98A8-4768-96E3-4F1E26AF10C9Q35160989-85EEE5B9-8D92-42F7-B1A8-4C9A63454697Q35187003-0F56FBCA-6276-446E-BD2E-858D35AB0EFCQ35583074-1E86B2C5-9AB2-4AA2-9D3E-4C6CFB864603Q35881636-882070A9-3139-4272-BEC1-A13420CBF731Q36123791-C49B0945-CF4F-4147-A007-97EF75426841Q36165434-590571AD-F644-43C3-A066-E4686D99941AQ36419763-F5D00CFA-48E3-4D54-B04D-CFADA036F7ADQ36526428-F938F220-D81F-4CF1-B33C-4D583A89C2A6Q37104407-89E23B0C-E396-43E6-AE8B-DC76F533D05DQ37450164-1163112E-E37E-418B-A2D9-24444CEECCFFQ37510465-208963D6-A7FA-49A3-B378-22690EF9EE98Q37535058-F4F950E2-DF01-4EC0-9FE2-39CBB374DCADQ37599340-6C174427-A43C-4819-AC4B-9D9394579DC8Q37815339-010E6E3B-C0D5-454E-A8D9-A0E1528FA123Q37979871-473F705A-A7FC-46A7-9BD4-A636C9A5FA66Q37994346-50E6B6FD-4E81-46CA-A5D6-8309D56144E9Q38286225-E0E9331C-6A26-4E68-8559-412787C5CECCQ39251880-5EB2742A-7164-42E2-96D0-6C6E9BC0E054Q39324215-78589C67-4AC8-44D8-9B7E-379EE5F38D33Q41146827-622B2086-699B-4402-BE28-85D3534C9F57Q41896124-DFA9EC1E-313C-44C7-8017-617868640325Q41909276-BCE0D2D7-5CD7-44A6-B977-D54FE722C151Q42371902-56A80AE6-0066-49CB-84A2-8918BC77077DQ42926952-3AE0287A-45CB-4319-A639-9C46BF530ABBQ44123921-A5155FBE-41CC-4C2E-B01F-BD42370728BFQ47887775-93F4D716-A200-48E0-90E9-564B84ACA9B0Q48110715-B15C2C34-5943-4506-8E16-AE8D49C6B8FEQ48123271-68B80520-AF0D-4585-9CC3-A80B722F7BECQ48228995-52593107-000F-413B-A93E-32B769533C3CQ48318293-809DA0DD-DEEB-42F3-99E6-393C48819C9BQ59125668-5623C21B-9C95-4E23-B237-D8FC3082D464
P2860
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@en
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@nl
type
label
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@en
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@nl
prefLabel
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@en
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@nl
P1433
P1476
Hypnosedative-induced complex behaviours : incidence, mechanisms and management.
@en
P2093
Christian R Dolder
Michael H Nelson
P304
P356
10.2165/0023210-200822120-00005
P577
2008-01-01T00:00:00Z
P6179
1024270607